Encompass Health CMO has shares withheld for taxes

Encompass Health Corp Chief Medical Officer Elissa Joy Charbonneau had 369 shares of Encompass Health common stock withheld at a price of $107.88 per share to cover tax obligations from vesting restricted stock.

Accepted by SEC EDGAR 03/03/2026 - 12:14 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Encompass Health Corp Chief Medical Officer Elissa Joy Charbonneau had 369 shares of Encompass Health common stock withheld at a price of $107.88 per share to cover tax obligations from vesting restricted stock. After this tax-withholding disposition, she directly holds 17,644.061 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 369 shares

Exercise Price or Tax Liability 1 txn

Insider Charbonneau Elissa Joy

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	369	$107.88	$40K

Holdings After Transaction: Encompass Health Common Stock — 17,644.061 shares (Direct)

Holdings Before and After: Encompass Health Common Stock, 18,013.061 to 17,644.061 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Encompass Health (EHC) report in this Form 4 for its Chief Medical Officer?

Encompass Health reported that Chief Medical Officer Elissa Joy Charbonneau had 369 shares of common stock withheld at $107.88 per share to satisfy tax obligations from vesting restricted stock, leaving her with 17,644.061 directly held shares afterward.

Was the Encompass Health (EHC) insider transaction an open-market sale?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. 369 shares were withheld or surrendered to cover the insider’s tax obligations triggered by the vesting of restricted stock, according to the filing footnote description.

How many Encompass Health (EHC) shares were involved in the CMO’s tax-withholding disposition?

The transaction involved 369 shares of Encompass Health common stock. These shares were withheld or surrendered specifically to pay the insider’s tax withholding obligations related to the vesting of restricted stock awards, as described in the accompanying footnote.

At what price were the Encompass Health (EHC) shares valued for the tax withholding?

The shares were valued at $107.88 per share for the tax-withholding disposition. This price was used to determine how many shares needed to be withheld to satisfy the insider’s tax obligations arising from the vesting restricted stock award.

How many Encompass Health (EHC) shares does the Chief Medical Officer hold after this Form 4 transaction?

Following the tax-withholding disposition, Chief Medical Officer Elissa Joy Charbonneau directly holds 17,644.061 shares of Encompass Health common stock. This post-transaction balance is explicitly stated as the total shares following the reported transaction in the Form 4 data.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Transaction code F represents payment of an exercise price or tax liability by delivering securities. In this case, 369 shares were withheld or surrendered to satisfy the insider’s tax withholding obligations related to the vesting of restricted stock, rather than a discretionary sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Charbonneau Elissa Joy

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/28/2026		F		369(1)	D	$107.88	17,644.061	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Ms. Charbonneau	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.